StonvexLoading…
StonvexStonvexStonvexCore line items from WB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.76B | $1.75B | $1.76B | $1.84B |
Operating Income | $464.82M | $494.32M | $472.93M | $480.47M |
Net Income | $449.02M | $300.80M | $342.60M | $85.56M |
EPS (Diluted) | $1.70 | $1.16 | $1.43 | $0.36 |
Total Assets | $7.09B | $6.50B | $7.28B | $7.13B |
Total Liabilities | $3.08B | $2.93B | $3.76B | $3.74B |
Cash & Equivalents | $2.30B | $1.89B | $2.58B | $2.69B |
Free Cash Flow OCF − CapEx | $477.11M | $578.43M | $636.05M | $520.97M |
Shares Outstanding | 245.55M | 244.27M | 242.61M | 234.19M |